Safety Escalating Repeat IV, in Stroke Patients

NCT00833989 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischaemic Attack, Transient

Interventions

DRUG: GSK249320
DRUG: PLACEBO

Sponsor

GlaxoSmithKline